Abstract Positron emission tomography (PET) myocardial perfusion imaging (MPI) has high diagnostic accuracy and prognostic value. PET-MPI can also be used to quantitatively evaluate regional myocardial blood flow (MBF). This technique also allows the calculation of the coronary flow reserve (CFR)/myocardial flow reserve (MFR), which is the ratio of MBF at peak hyperemia to resting MBF. Coronary computed tomography angiography (CTA) is a non-invasive method for accurate detection and exclusion of high-grade coronary stenoses, when compared to an invasive coronary angiography reference standard. However, CTA assessment of coronary stenoses tends toward overestimation, and CTA cannot determine physiologic significance of lesions. Recent advances in computational fluid dynamics and image-based modeling permit calculation of non-invasive fractional flow reserve derived from CT (FFR CT ), without the need for additional imaging, modification of acquisition protocols, or administration of medications. In this review, we cover the CFR/MFR assessment by PET and FFR assessment by CT.
Introduction
Positron emission tomography (PET) myocardial perfusion imaging (MPI) allows accurate measurement of myocardial hypoperfusion and function at stress and rest. Absolute myocardial blood flow (MBF) in milliliter/minute/gram can be quantified using PET imaging in the same study. This technique allows the calculation of the coronary flow reserve (CFR) or myocardial flow reserve (MFR), which is the ratio of MBF at peak hyperemia to resting MBF. Fractional flow reserve (FFR) is an invasive approach and functional assessment, which measures the stenosis related decline in distal coronary pressure during maximum hyperemia. FFR at the time of invasive coronary angiography is the gold standard for determining functional consequences of coronary stenosis.
Coronary CT angiography (CTA) is a non-invasive method for accurate detection and exclusion of high-grade coronary stenoses, when compared to an invasive coronary angiography reference standard. Recently, computation of FFR from CT (FFR CT ) has emerged as a novel non-invasive method that demonstrates high diagnostic performance for identification and exclusion of patients and coronary lesions that cause ischemia. In this review, we discuss CFR/MFR assessment by PET and FFR assessment by CT.
PET Tracers
Amongst several available myocardial perfusion PET tracers, those most widely used in clinical practice include Rubidium-82 ( 82 Rb) and Nitrogen-13-Ammonia ( 13 N-ammonia). In addition to 82 Rb and 13 N-ammonia, cardiac PET perfusion can also be performed using 15 O-water 18 F-flurpiridaz. Each of these radiotracers displays different characteristics, which offer both advantages and disadvantages.
Rubidium-82

82
Rb is a potassium analog that is a generator product with a physical half-life of 76 seconds [1] and kinetic and biological properties similar to those of Thallium-201 in single-photon emission computed tomography (SPECT) [1] . Because of the distinct advantage of not requiring an on-site cyclotron, 82 Rb is the most widely used radionuclide for assessment of myocardial perfusion with PET [1] . Recent data suggest that the total-body effective dose from a stress-rest myocardial perfusion study performed with 82 Rb is approximately 4 mSv [2, 3] .
Nitrogen-13-Ammonia
13
N-ammonia is a cyclotron product and has a physical half-life of 9.96 min [4] . After injection, 13 N-ammonia rapidly disappears from the circulation after its cell-trapping conversion to glutamine, permitting the acquisition of images of excellent quality. Although the sequestration of 13 N-ammonia in the lungs is usually minimal, it may be increased in patients with depressed left ventricular (LV) systolic function or chronic pulmonary disease and, occasionally, in smokers [4] . This may, in turn, adversely affect the quality of the images. In these cases, it may be necessary to increase the time between injection and image acquisition to optimize the contrast between myocardial and background activity. 13 N-ammonia exhibits high resolution and extraction characteristics, but its use is limited to the sites with an on-site cyclotron. The total-body effective dose from a stress-rest myocardial perfusion study performed with 13 N-ammonia is less than 3 mSv [5] . [7] . 15 O-water images of the myocardium are usually of lower count density, due to its short physical and biological half-life in the myocardium (2.4 min), thereby limiting the visual or semiquantitative assessment of regional myocardial perfusion from the static images [8] .
Oxygen
Flurpiridaz F-18 Flurpridaz-F-18 has recently been introduced as a novel radiotracer for myocardial perfusion imaging [9] . Because of its smaller kinetic positron energy and, consequently, short positron range, F-18 tagged agent can take full advantage of PET superior spatial resolution. 18 Fflurpiridaz has a relatively long physical half-life of 110 min as compared to currently available tracers and therefore does not require cyclotron on site. Phase 1 and phase 2 clinical studies have been completed with 18 F-flurpiridaz, and phase 3 studies are currently ongoing [10] . Results of early clinical trials suggest that both pharmacologically and exerciseinduced stress PET imaging protocols can be completed more rapidly and with lower patient radiation exposure than with SPECT tracers [11] . Preliminary data suggested that absolute myocardial blood flow may be determined using 18 Fflurpiridaz myocardial perfusion PET imaging [12, 13] (Fig. 1 ).
CFR/MFR by PET
With standard list-mode acquisition offered by modern PET/ CT scanners, dynamic perfusion images can be obtained with a single injection of the radiopharmaceutical and without additional imaging time or radiation to the patient [1] . Dynamic imaging is essential for evaluating absolute MBF. To obtain MBF values, image-derived time activity curves from the arterial blood and myocardial tissue regions are used as inputs to a tracer kinetic model. The kinetic model describes the exchange of tracer between the blood and the tissue over time. The rate of uptake of the tracer into the myocardial tissue provides an estimate of MBF on an absolute scale of mL/min/ g. This technique also allows the calculation of the CFR/MFR, which is the ratio of MBF at peak hyperemia to resting MBF. Automated image analysis tools are required for reliable and robust clinical use of dynamic data for MBF quantification [14] . These clinical tools combine advances in the automated detection of the myocardium with established kinetic modeling techniques and allow rapid and automated analysis of dynamic scans.
Different modeling tools for calculation of MBF and MFR have been developed by several groups [15] [16] [17] [18] [19] , each of which employ different methods of segmenting and sampling of the myocardial and blood pool activity to obtain input curves. Nevertheless, the agreement in absolute values of MBF and CFR/MFR is relatively high. In a comparative study, three existing clinical implementations of the kinetic modeling packages for the computation of regional stress and rest flow and CFR/MFR for 13 N-ammonia with 1-tissue and 2-tissue compartment models were compared to each other, demonstrating excellent agreement in MBF and MFR for each vascular territory [15] . Similarly, flow and flow reserve obtained with 82 Rb tracers showed very good agreement in a comparison among different software programs for the routine kinetic quantification of data from multiple sites, scanners, and protocols [19] .
Added Value of MBF, CFR/MFR Measurements by PET
Detecting Coronary Artery Disease MBF analysis may be able to identify multivessel disease and predict the extent of ischemia more accurately than static perfusion imaging [7, 20] . The ability to quantify absolute MBF with stress PET-MPI permits identification of patients in whom the relative regional distribution of tracer may appear normal because of a balanced reduction of blood flow [21, 22••] (Fig. 2) . A preliminary report showed that quantification of MFR in 13 N-ammonia PET/CT MPI provides added diagnostic value for detection of coronary artery disease (CAD) over visual analysis of static MPI [23•] . However, further investigation is warranted because other studies by quantitative analysis of static PET images alone have demonstrated very high sensitivity and accuracy [24] [25] [26] . Hajjiri et al. reported that absolute quantification of hyperemic MBF is superior to measurements of relative tracer uptake for identification of hemodynamically significant CAD using 13 N-ammonia PET [27] . However, numerous caveats apply to this study; in particular, different methods (measure tracer count by placing region of interest over the myocardial segments) from other investigators for relative perfusion assessment were used. Another report using quantitative 82 Rb PET demonstrated a nonlinear decrease in hyperemic MBF as the severity of coronary artery stenosis increased [28] . Using 15 O-water, a threshold of pharmacologically induced hyperemic MBF of 2.5 ml/g/min was proposed as accurate in the identification of epicardial lesions of >50 % diameter stenosis [29] . Two studies demonstrated better diagnostic performance of quantitative analysis with 
Detecting Microvascular Dysfunction
Hyperemic MBF during pharmacologic vasodilation may be of use to identify microcirculatory dysfunction, as it can be diminished due to coronary microvascular disease in patients with or without focal CAD lesions on coronary angiography but with cardiovascular risk factors [31] [32] [33] . For example, in insulin-resistant individuals with normal stress-rest PET-MPI, concurrent MBF quantification has uncovered abnormalities in endothelium-related MBF responses to cold pressor testing, whereas hyperemic flows during pharmacologic vasodilation were preserved [34] . Indeed, coronary circulatory dysfunction in individuals with increasing body weight may progress from an impairment in endothelium-dependent coronary flow response to cold pressor testing, in the early stages of overweight, to an impairment of the predominantly endotheliumindependent hyperemic flows during dipyridamole stimulation in the later stages of obesity [31] . An inverse relationship between CFR/MFR and plasma glucose levels has been shown in patients with type 2 diabetes mellitus, providing direct evidence of an adverse effect of raised plasma glucose c o n c e n t r a t i o n o n d i a b e t e s -r e l a t e d c o r o n a r y microvasculopathy [34] . Assessment of CFR/MFR with PET allows characterization of endothelial dysfunction and [35] . Also, CFR/MFR results were found to stratify patients-both those with normal and those with abnormal stress perfusionwith respect to their risk of adverse cardiovascular events. PET-MPI in combination with quantification of regional MBF or regional CFR/MFR may therefore improve our ability to identify patients who might benefit from revascularization and/or intensified medical therapy, and may provide better prognostic estimates of future cardiac events.
Strengths and Limitations
In addition to absolute quantification of myocardial perfusion, because stress images can be obtained immediately after infusion of a vasodilator, the results of a stress gated PET represent peak stress wall motion (unlike in SPECT where stress images are acquired up to 45 minutes after stress). Although vasodilator-stress gated images are not equivalent to exercise gated images, investigators have found that the failure to show an increased ejection fraction on stress gated PET images compared with rest images is strongly associated with the presence of extensive CAD [40] . This ejection [60] fraction reserve has been shown to be prognostically significant [41] . PET perfusion stress/rest imaging (including absolute quantification of myocardial perfusion) can be performed with much lower radiation doses (< 4 mSv), especially on new 3D PET/CT scanners [42] .
Almost all new PET scanners models are currently sold in the hybrid PET/CT configuration, in which the CT-based attenuation correction has replaced the traditional transmission CT-based attenuation correction technique. CT-based attenuation correction for PET studies has proven challenging because of the effects of possible respiratory motion in general [43] and for myocardial perfusion studies more specifically [44, 45] . It has been shown that there are significant differences between traditional transmission CT-based attenuation correction and CT-based attenuation correction applied to cardiac PET/CT studies, which may remain after alignment of CT maps to emission data [46] . This problem is not yet fully resolved; however, careful visual verification of alignment usually ensures that these artifacts are minimized.
Although absolute quantification of myocardial perfusion has a great clinical potential, there are several limitations that need to be recognized. The knowledge of optimal cut-off values for absolute perfusion needs to be studied in large populations and for various tracers. Furthermore, additional information is needed about expected flow and flow reserve values in different subpopulations such as diabetic and obese patients, patients with heart failure and revascularized patients. Further, mean flow rate measurements may be obtainable from PET-based perfusion imaging, potential sources of errors in measurement, including the effect of high driving pressure and high resting flow rates, are still being characterized. Furthermore, still unexplored is how CCR/MFR may differentiate between patients who have epicardial stenoses and patients who have abnormalities with subendocardial microvascular perfusion.
FFR Assessment by CT
Recent advances in computational fluid dynamics (CFD) enable calculation of coronary flow and pressure fields from anatomic image data [47] . Applied to CT, these technologies enable calculation of FFR, defined as the ratio of maximal myocardial blood flow through a diseased artery to the blood flow in the hypothetical case that this artery is normal, without additional imaging or medications (Fig. 3) .
Coronary flow and pressure can be computed by solving the governing equations of fluid dynamics, which have been known in their current form as the NavierStokes equations. These equations are solved for the unknown pressure, which varies with position and time, and for the three components of blood velocity, each of which are functions of position and time. The physical properties of blood, the fluid density, and the fluid viscosity, are assumed when solving these equations. For realistic patient-specific models of the human coronary arteries, a numerical method must instead be used to approximate the governing equations and obtain a solution for velocity and pressure at a finite number of points [48•] .
Coupled to CFD, the computation of FFR from CT requires methods to extract models from image data and incorporate boundary conditions that model the effect of the microcirculation [48•] . For that, image segmentation algorithms extract the luminal surface of the major vessels and branches, up to the limits imposed by the resolution of CT. Further, simulating maximum hyperemia by modeling mimics the effect of [61] adenosine on reducing the peripheral resistance of the coronary microcirculation downstream of the epicardial arteries extracted from CT. This change in resistance of normal coronary arteries provides an upper bound on the maximal change that can be achieved in patients with microcirculatory dysfunction and represents an identical assumption made with invasive FFR, wherein the hyperemic microcirculatory resistance distal to a stenosis is assumed to be the same as that in the hypothetical case that the coronary arteries have no disease [49] . Upon generation of a discrete model of the ascending aorta and epicardial coronary arteries, and the definition of the boundary conditions for rest and hyperemic conditions, FFR CT can then be determined by solving the equations of blood flow for the velocity and pressure fields. FFR CT is then obtained by normalizing the mean hyperemic pressure field by the average mean hyperemic pressure in the aorta. The end result is a complete spatial distribution of FFR CT (Fig. 4) .
Diagnostic Performance of FFR CT
Several studies showed incremental value of FFR CT in diagnosis of CAD. In the Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve (DISCOVER-FLOW) trial, compared to invasive FFR, noninvasive FFR derived from CT (FFR CT ), demonstrated pervessel accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for lesions causing ischemia of 84.3 %, 87.9 %, 82.2 %, 73.9 %, 92.2 %, respectively, for FFR CT [50] . The performance of FFR CT was superior to CT stenosis for diagnosing ischemic lesions, the latter of which demonstrated an accuracy, sensitivity, specificity, PPV, and NPVof 58.5 %, 91.4 %, 39.6 %, 46.5 %, 88.9 %, respectively. More recently, the Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (DeFACTO) trial-a pivotal multicenter international study evaluating FFR CT against CT for diagnostic 
Strengths and Limitations
CTA is a non-invasive method for accurate detection and exclusion of high-grade coronary stenoses, when compared to an invasive coronary angiography reference standard [53] . Although current generation CTA exhibits high NPV to exclude ≥50 % obstructive coronary artery stenosis, CTA cannot determine physiologic significance of lesions and even among CT-identified obstructive stenoses confirmed by invasive coronary angiography, fewer than half are ischemia-causing [54, 55] . Thus, FFR CT has emerged as a novel non-invasive method that demonstrates high diagnostic performance for identification and exclusion of patients and coronary lesions that cause ischemia [51••] . Further FFR CT possesses high diagnostic performance for diagnosis of ischemic for lesions of intermediate stenosis severity (30 % to 69 %). Notably, the high sensitivity and negative predictive value suggest the ability of FFR CT to effectively rule out intermediate lesions that cause ischemia. In addition to FFR CT , CT also enables assessment of several coronary atherosclerotic plaque characteristics with high accuracy; including positive arterial remodeling; low attenuation plaque (marker for necrotic lipid laden intraplaque core); and spotty intra-plaque calcification, which have been related to acute coronary syndrome [56] [57] [58] [59] . FFR CT offers several operational advantages in that it does not require modification of CT angiography protocols, does not require administration of additional medications beyond what is typically administered for CTA, and does not confer any additional radiation. Yet this technology, while now studied in three prospective multicenter studies, is not without limitations. The calculation of FFR CT is based upon a proprietary algorithm that is at present available only through a single commercial entity. Further, given the computational time and intensity required for calculation of FFR CT , the workflow of obtaining this as-yet not FDA approved software requires Fig. 4 (continued) sending of images to a 3rd party rather than on-site assessment. Given the importance of coronary artery segmentation, technical artifacts such as misregistration or coronary motion may affect measures.
Conclusions
Stress/rest PET perfusion imaging including absolute myocardial blood flow imaging can be performed in one scanning session. PET-MPI in combination with quantification of regional MBF or regional CFR/MFR may improve the ability to identify patients who might benefit from revascularization and may provide better prognostic estimates of future cardiac events. Recent advances in computational fluid dynamics enable calculation of non-invasive FFR derived from CT (FFR CT ). Prospective international multicenter trial demonstrates FFR CT is superior to measures of CTA stenosis severity for determination of lesion-specific ischemia. Further comparative and/or complementary studies are needed to precisely identify the proper clinical role of FFR CT in the context of traditional MPI imaging.
